First-ever international Arthrofibrosis Awareness Day in April 2023!
April 20, 2023
I have big news – we’re going to have the first-ever international Arthrofibrosis Awareness Day! And we need your help to make the AAD the huge success it needs to be to make “arthrofibrosis” a word that clinicians know worldwide. At this stage we plan to hold this day on the 20th of April 2023, however, this may change depending on the needs of participating organisations.
New Review on Pharmacological Therapies
August 15, 2022
A new review titled “Pharmacological Therapies for Connective Tissue Fibrosis in Orthopaedics” by N. Disser et.al has been published in The American Journal of Sports Medicine.
They summarise by stating “Based on our review, it would appear that over-the counter food supplements and ‘‘nutraceuticals’’ hold promise as agents to prevent connective tissue fibrosis with a good safety profile. In particular, EGCG and quercetin appear to be safe and reasonable candidates for further study. FDA-approved medications that may be considered for off-label use for prevention of connective tissue fibrosis include losartan, anakinra, and sotatercept.”
The materials presented in this site are provided voluntarily as a public service. It is of a general nature, based on the scientific literature. The information and advice provided is made available in good faith but is provided solely on the basis that readers will be responsible for managing their own assessment of the matters discussed herein and that they should verify all relevant representations, statements and information. Please consult your doctor.